Condition

Kidney Transplant; Complications

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 22 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials22
Recruiting5
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

22 shown
Vascular Complications After Kidney TransplantationNCT07531966 · 2026-05-22
RECRUITING
The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR StudyNCT06059664 · 2024-04-23
RECRUITING
Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant RecipientsNCT06140537 · 2024-02-01
RECRUITING
Effect of Empagliflozin vs Linagliptin on Glycemic Outcomes,Renal Outcomes & Body Composition in Renal Transplant Recipients With Diabetes MellitusNCT06095492 · 2023-10-30
RECRUITING
Use of CGM in Kidney Transplant RecipientsNCT04783441 · 2021-06-29
RECRUITING
StOPping Hypertension and imprOving Children's Lives After KidnEy TranSplantationNCT06589947 · 2024-09-16
NOT_YET_RECRUITING
Feasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) ProgramNCT06688825 · 2024-09-16
COMPLETED
Empagliflozin Versus Linagliptin in Renal Ransplant Recipients With Diabetes MellitusNCT06098625 · 2023-11-10
UNKNOWN
Define Predictors for Posttransplant Diabetes Mellitus StudyNCT06440330 · 2023-09-01
UNKNOWN
Continuous Glucose Monitoring (CGM) in Kidney-Transplanted AdultsNCT05352230 · 2023-04-15
TERMINATED
Home Blood Pressure Monitoring in Kidney Transplant RecipientsNCT04364126 · 2022-12-15
TERMINATED
CardioRenal Effects of SGLT2 Inhibition in Kidney Transplant RecipientsNCT04906213 · 2022-07-25
TERMINATED
Dietary Intervention to Improve Kidney Transplant OutcomesNCT05449496 · 2022-06-27
ACTIVE_NOT_RECRUITING
HHV8 and Solid Organ TransplantationNCT05081141 · 2021-09-15
UNKNOWN
AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNceNCT05216172 · 2019-12-13
COMPLETED
The POWERED Study: Prophylaxis With Metformin to Prevent PTDMNCT05240274 · 2019-01-25
COMPLETED
Efficacy and Safety of Empagliflozin in NODATNCT03642184 · 2018-07-14
TERMINATED
The wEight Management in Renal Transplant Online Study (ExeRTiOn)NCT03699059 · 2018-05-31
COMPLETED
Effect of Dietary Salt Reduction on Blood Pressure in Kidney Transplant RecipientsNCT03373500 · 2017-10-11
UNKNOWN
Project LIFT - Promoting Healthy Behavior Through a Wearable Fitness Device and Financial IncentivesNCT03221465 · 2017-03-01
COMPLETED
SPRINT Trial Type Blood Pressure Measurements in Patients After Kidney TransplantationNCT03094702 · 2017-01-01
COMPLETED
Incisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled TrialNCT03010137 · 2015-12-01
TERMINATED

Common interventions

Leading sponsors

Trial status mix

COMPLETED6
RECRUITING5
TERMINATED5
UNKNOWN4
ACTIVE_NOT_RECRUITING1
NOT_YET_RECRUITING1

Phase mix

NA12
PHASE24
PHASE42
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.